Publication: Pure Flat Epithelial Atypia of the Breast on Core Needle Biopsy: No Need for Surgical Excision
Issued Date
2021-11-01
Resource Type
ISSN
22288082
Other identifier(s)
2-s2.0-85123798012
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Siriraj Medical Journal. Vol.73, No.11 (2021), 727-731
Suggested Citation
Warapan Numprasit, Norasate Samarnthai, Tichakorn Srianuchat Pure Flat Epithelial Atypia of the Breast on Core Needle Biopsy: No Need for Surgical Excision. Siriraj Medical Journal. Vol.73, No.11 (2021), 727-731. doi:10.33192/Smj.2021.93 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/77674
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Pure Flat Epithelial Atypia of the Breast on Core Needle Biopsy: No Need for Surgical Excision
Other Contributor(s)
Abstract
Objective: From previous data, pure flat epithelial atypia (FEA) of the breast demonstrated on core needle biopsy (CNB) was related to malignant upgrading. However, FEA itself is not an independent factor for developing breast cancer; therefore, the necessity of subsequent surgical excision is controversial. This study aimed to evaluate the upgrade rate of FEA after surgical excision and to demonstrate the necessity of surgical excision in FEA lesions identified on CNB. Materials and Methods: This retrospective study involved a review of the clinical features, mammographic and ultrasound findings, and pathological reports of patients with pure FEA found from CNB specimens between January 2010 to January 2019. FEA accompanied with atypical ductal hyperplasia, atypical lobular hyperplasia, ductal carcinoma in situ (DCIS), and invasive cancer (IC) in ipsilateral breast were excluded. FEA upgrade is defined as patients with in situ or invasive cancer presented in surgical excision specimens. The breast imaging results of pure FEA and FEA upgrade subsets were compared. Results: In total, 45 pure FEA specimens were revealed from CNB; of which, 6 of the pure FEA (13.33%) did not undergo further surgical excision, however, they showed no recurrence during follow-up (median follow-up time: 2.68 years). The majority of FEA cases were detected by mammography in 39 patients (86.67%). Of the 45 patients, 32 were classified into BI-RADS 4B (71.11%), 11 as BI-RADS 4A (24.44%), and 2 as BI-RADS 4C (4.44%). One patient was upgraded to DCIS (2.7%). BI-RADS classification did not differ between upgrade FEA and non-upgrade FEA groups (p=0.49). Conclusion: Only a 2.7% upgrade rate, omitting the surgical excision of pure FEA from CNB, was possible. Even though our study could not demonstrate a correlation between FEA upgrade and radiological findings, BIRADS 4A was less likely to carry the malignant cells. Furthermore, segmental microcalcification tended to be associated with upgraded lesions, but not significantly